East Suffolk and North Essex NHS Foundation Trust - Colchester Hospital

The East Suffolk and North Essex NHS Foundation Trust - Colchester Hospital incorporates Colchester General Hospital https://www.esneft.nhs.uk/
Chemotherapy toxicity data presented at trust level because 72% of data was coded at trust level.

Between 2019-2021, outcomes for Colchester General Hospital and Ipswich Hospital were reported under East Suffolk and North Essex NHS Foundation Trust

View East Suffolk and North Essex NHS Foundation Trust outcomes

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Surgical services:
    • Robotic surgery
  • Advanced disease services:
    • Dedicated Specialist Advanced MDT
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • Availability of 24 hour palliative care advice
    • 7-day access to face-to-face palliative care services
    • On-site psychology services

Data Quality
All Patients: Trust Network National
Number of patients in Audit 307 2310 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 91 86 86
– Performance status (%) 98 98 89
Patients having major resection: Trust Network National
Number of patients in Audit 152 1175 19631
ASA grade 1 (%) 14 7 9
ASA grade 2 (%) 53 55 53
ASA grade 3 (%) 28 36 31
ASA grade 4+ (%) 1 2 2
ASA grade not recorded (%) 5 2 4
Data completeness of:
7 Audit items for risk-adjustment (%) 45 88 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients
All Patients: Trust Network National
Number of patients in Audit 307 2310 35779
Seen by Clinical Nurse Specialist (%) 89 86 88

Management of patients having major resection
Patients having major resection: Trust Network National
Number of patients in Audit 152 1175 19614
Distant metastases (%) N/A 4 5
Urgent or emergency surgery (%) 7 12 15
At least 12 lymph nodes excised (%) 44 81 84
Laparoscopic surgery attempted (%) 59 68 72
Risk-adjusted length of stay > 5 days (%) 50 58 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 79 N/A 10747
Adjuvant chemotherapy (%) 66 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 71 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 27 N/A 22

Rectal cancer patients
Patients having major resection: Trust Network National
Number of patients in Audit 40 N/A 4251
Neoadjuvant therapy (%) 9 N/A 33
Circumferential resection margin: Recorded (%) 45 86 89
Circumferential resection margin: Negative (%) 43 80 83
Rectal volume 40 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 138 1244 19644
APER/Hartmanns (%) 41 35 37

Compare trust outcomes

Copyright © 2024 National Bowel Cancer Audit | Lovingly Crafted by Mixd